
TasWeekend – In the Business of Hope
Groundbreaking work, through a series of cutting-edge clinical trials, being undertaken by two of the state’s leading cancer specialists, Louise Nott and Michael Jones, is
If you are not yet an ANZUP member then join our large
multidisciplinary network of urogenital and prostate cancer
researchers, clinicians, nurses, psychologists, scientists, allied
health and consumer representatives. Membership is free.
If you are a member of the community and would like to learn more about below the belt cancers, then join ‘Friends of ANZUP’.
All of the major milestones in controlling cancer worldwide have
come through clinical trials, but we still have a long way to go to
help every person affected, at risk or diagnosed with this disease.
We have clinical trials across each cancer type, in various stages
of progress: in activation, open to patient recruitment, in follow
up and completed trials.
Telehealth and Teletrials
Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations.
Teleheath and Teletrials
Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations, or in self-isolation due to COVID-19. Teletrials also allows trials recruitment and activity to continue.
Groundbreaking work, through a series of cutting-edge clinical trials, being undertaken by two of the state’s leading cancer specialists, Louise Nott and Michael Jones, is
A randomised clinical trial aiming to improve survival in advanced prostate cancer by adapting treatment with a personalized dosing strategy has enrolled its first participants.
Dickon Hayne accepted the BJUI Global Prize for 2023 for the Pain-Free TRUS B article that featured in BJUI in 2022, at the USANZ meeting
PSMA and FDG-PET as predictive and prognostic biomarkers TheraP biomarker Oct 2022 (1)Previously, results from the TheraP trial showed that treatment with lutetium-177 [¹⁷⁷Lu]Lu-PSMA-617 improved
Groundbreaking work, through a series of cutting-edge clinical trials, being undertaken by two of the state’s leading cancer specialists, Louise Nott and Michael Jones, is
A randomised clinical trial aiming to improve survival in advanced prostate cancer by adapting treatment with a personalized dosing strategy has enrolled its first participants.
Dickon Hayne accepted the BJUI Global Prize for 2023 for the Pain-Free TRUS B article that featured in BJUI in 2022, at the USANZ meeting